Dementia & Diabetes: How the Two Are Connected

As an approximation, there are over forty million people living in the United States alone who are living with either Type 1 or Type 2 diabetes, with over a quarter being over the age of sixty-five.

These days, thanks to the development and discoveries in the world of medicine, people are living almost to quadruple the age their ancestors did, but as a natural result, older people tend to suffer more illnesses, with diabetes being no exception.

Continue reading to discover how dementia and diabetes are connected.

The Impact of High Insulin & High Blood Sugar on the Brain

Currently, medical professionals and research scientists are not entirely sure as to the direct link, scientifically speaking, between dementia and diabetes, but they are positive that high levels of insulin or high levels of sugar in the body harm the brain in three ways.

Firstly, high blood sugar places an enormous amount of strain on the blood vessels of your body, and damaged vessels located in the brain can contribute to accentuated cognitive decline.

Secondly, high blood sugar also causes serious inflammation, which could affect brain cells, leading to the onset of dementia.

Thirdly, too much insulin results in a negative effect on the natural balance of different chemicals in the brain.

The Primary Ways to Reduce the Risk of Contracting Diabetes

The Alzheimer’s Association keeps it simple with its advice for people of any age or lifestyle for effective ways to reduce the risk of contracting diabetes, and alongside medical doctors’ advice and guidance given to patients on the subject every day, you would do well to heed the following:

  • Seek to control and maintain a healthy blood pressure
  • Lose weight if you are currently overweight
  • Eat low-fat, natural, and highly nutritious foods
  • Make sure you exercise for at least twenty minutes a day
  • Stop smoking and regulate your alcohol intake

It would also be worth noting that reputable and prestigious assisted living facilities like those at Fort Lauderdale memory care are part and parcel of the community, and should your loved one be living with dementia, this could be something worth considering.

Diabetes & Dementia

Although, as previously stated, there is as of yet no ‘black and white’ link between dementia and diabetes, research has proven many facts about the relationship between the two.

Fundamentally, as proven by a study carried out by a Northern California drug research company in early 2021, there is a much greater risk of people with Type 1 diabetes contracting dementia; as a result, a ninety-three percent more likelihood in fact. This is due to the simple fact that too much sugar in the body for a prolonged period of time leads to organ damage, your brain, of course, being the most complex.

Another notable finding from the continuing extensive scientific research into the relationship between diabetes and dementia includes the APP gene, which affects the pathway for insulin distribution being directly connected with patients with dementia.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”